24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
SORALIEVA 200MG is an Tablet medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | SORALIEVA 200MG |
|---|---|
| Composition | Sorafenib Tablets 200mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Tablet |
| Packaging | Btl (30 tab) |
| Country of Origin | India |
Sorafenib Tablets IP 200mg (Sorafenib Tablets 200mg) is a widely used Tablet medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
SORALIEVA 200MG (Sorafenib Tablets 200mg) is a targeted anticancer medicine used in the treatment of specific types of liver cancer, kidney cancer, and thyroid cancer. It contains Sorafenib Tosylate, a multikinase inhibitor that helps slow the growth and spread of cancer cells by blocking certain proteins and signaling pathways involved in tumor development and blood vessel formation.
Cancer cells require a constant supply of nutrients and oxygen to grow and spread. Sorafenib works by targeting multiple kinases involved in cancer cell proliferation and angiogenesis (the formation of new blood vessels that feed tumors). By blocking these pathways, SORALIEVA 200MG helps reduce tumor growth and may slow disease progression in eligible patients.
Unlike conventional chemotherapy, Sorafenib is a targeted therapy designed to interfere with specific molecular mechanisms that support cancer growth. This approach makes it an important treatment option in modern oncology, especially for patients with advanced or metastatic cancers.
SORALIEVA 200MG is commonly prescribed for:
• Hepatocellular Carcinoma (HCC) – Liver Cancer
• Advanced Renal Cell Carcinoma (RCC) – Kidney Cancer
• Differentiated Thyroid Carcinoma (DTC)
• Advanced or Metastatic Solid Tumors
• Long-Term Targeted Cancer Therapy Programs
The medicine is often recommended when surgery or other treatment options are not suitable, or when cancer has progressed despite previous therapies.
Manufactured under stringent pharmaceutical quality standards, SORALIEVA 200MG is designed to provide reliable therapeutic performance and consistent quality. It should only be used under the supervision of qualified oncologists or healthcare professionals experienced in cancer treatment.
Patients undergoing treatment with Sorafenib may require regular blood tests, liver function monitoring, blood pressure assessments, and imaging studies to evaluate treatment effectiveness and manage potential side effects.
Due to its effectiveness in advanced cancer management, SORALIEVA 200MG has become an important component of modern targeted oncology treatment protocols worldwide.
SORALIEVA 200MG (Sorafenib Tablets 200mg) is primarily used for the treatment and management of certain advanced cancers.
SORALIEVA is widely used in the treatment of advanced liver cancer, helping slow tumor growth and disease progression.
Doctors may prescribe Sorafenib for patients with advanced kidney cancer requiring targeted therapy.
The medicine is used in certain patients with differentiated thyroid cancer that no longer responds to radioactive iodine treatment.
In some cases, Sorafenib may be included in treatment plans for advanced cancers involving abnormal cell growth.
Targeted therapy with Sorafenib can support long-term disease control in selected patients.
The medicine helps prevent the development of new blood vessels that tumors need for growth and survival.
Sorafenib belongs to a class of medicines known as multikinase inhibitors.
SORALIEVA works by:
• Blocking multiple cancer growth pathways
• Inhibiting tumor cell proliferation
• Reducing blood vessel formation (angiogenesis)
• Slowing cancer progression
• Limiting tumor nutrient supply
• Supporting targeted cancer treatment
This dual mechanism helps control tumor growth and improve disease management in eligible patients.
Like other targeted cancer therapies, SORALIEVA 200MG may cause side effects in some patients. The severity and frequency of side effects vary among individuals.
Patients may experience tiredness, weakness, or reduced energy levels.
Loose stools and digestive discomfort are commonly reported.
Redness, swelling, pain, or sensitivity in the palms and soles may occur.
Some individuals may notice reduced appetite during treatment.
Gradual weight loss may occur in certain patients.
Sorafenib may cause elevated blood pressure that requires monitoring.
Skin irritation, redness, dryness, or rash may develop.
Mild nausea or stomach discomfort may occur during therapy.
Some patients may experience hair thinning or hair loss.
Although uncommon, certain side effects require immediate medical attention.
• Severe chest pain
• Difficulty breathing
• Severe bleeding
• Heart rhythm abnormalities
• Severe hypertension
• Signs of liver damage
• Severe allergic reactions
• Black or bloody stools
• Severe abdominal pain
Patients should contact their healthcare provider immediately if any serious symptoms develop.
The dosage of SORALIEVA 200MG (Sorafenib Tablets 200mg) should always be determined by a qualified healthcare professional.
Treatment dosage depends on the specific cancer being treated.
Advanced disease may require different treatment approaches and monitoring.
Patients with liver-related conditions may require dosage adjustments.
Doctors may modify treatment based on effectiveness and side effect management.
Age, body weight, and general medical condition influence treatment planning.
• Take the medicine exactly as prescribed.
• Swallow the tablets whole with water.
• Do not crush, chew, or break the tablets.
• Follow the treatment schedule carefully.
• Attend regular medical check-ups and monitoring visits.
• Do not stop treatment without consulting your doctor.
Proper adherence to the prescribed treatment plan helps maximize therapeutic benefits.
Before starting treatment, patients should inform their doctor if they have:
• Liver disease
• Heart disease
• High blood pressure
• Kidney disorders
• Bleeding disorders
• Previous cancer treatment complications
Patients should also discuss all medications, supplements, and herbal products they are currently taking to avoid possible drug interactions.
Pregnant or breastfeeding women should only use this medicine if specifically recommended by a healthcare professional.
• Store in a cool and dry place.
• Protect from direct sunlight and moisture.
• Keep out of reach of children.
• Store at recommended room temperature.
• Advanced targeted cancer therapy
• Effective multikinase inhibitor formulation
• Supports liver, kidney, and thyroid cancer treatment
• Trusted oncology treatment option
• Manufactured under strict pharmaceutical quality standards
• Suitable for modern precision oncology programs
• Reliable long-term disease management support
It is mainly used for the treatment of liver cancer, kidney cancer, and certain types of thyroid cancer.
Sorafenib is a targeted anticancer medicine that blocks cancer growth pathways and tumor blood vessel formation.
No, it is a targeted therapy medicine that works differently from traditional chemotherapy.
Yes, Sorafenib is designed to slow tumor growth and help manage advanced cancers.
Yes, elevated blood pressure is a known side effect and should be monitored during treatment.
Yes, doctors typically recommend blood tests, blood pressure monitoring, and routine medical assessments throughout treatment.
No, treatment should only be stopped under medical supervision.
Yes, this medicine should always be used under the guidance of qualified healthcare professionals experienced in oncology care.